Michelle Gilliatte

Family Medicine physician in Indianapolis, Indiana — also lists obesity medicine in the CMS registry.

Practice Details

Address
8901 River Crossing Blvd Ste A
Indianapolis, IN 46240
Geocoded location: 39.9164, -86.1065
Taxonomy
Family Medicine
Credential
M.D.
NPPES Enumeration
Listed with NPPES since 2016
Sole Proprietor
Yes
Provider Gender (NPPES)
Female
NPPES Record Updated
July 2025

Specialty taxonomies on file (2)

  • Bariatric Surgery
    Family Medicine, Obesity Medicine
  • Family Medicine
    Primary

All specialty taxonomies this NPI reports in the CMS National Provider registry. A taxonomy on file reflects a self-reported designation, not confirmation of current services.

About This Clinician

Michelle Gilliatte is a Family Medicine physician in Indianapolis whose NPPES record also lists an obesity-medicine or bariatric-medicine taxonomy as a secondary specialty. Primary-care and family-medicine clinicians who carry this secondary designation are among those most likely to actively manage GLP-1 prescribing, though this registry entry does not confirm current prescribing practices — call ahead to confirm.

Locally, this is 1 of 770 Family Medicine practices in Indianapolis carrying this exact taxonomy in our directory.

What to expect at a Family Medicine visit

Family-medicine practices manage routine and preventive care for all ages. A weight- or GLP-1-related visit often involves:

  • A general health and medication review in the context of your overall care.
  • Screening labs where indicated (A1c, metabolic panel) before starting therapy.
  • A conversation about whether GLP-1 therapy or a referral to a specialist is the better fit.
  • Coordination with your insurance on coverage and prior authorization.

This is general guidance for family medicine practices, not a description of Michelle Gilliatte's specific protocol, services, or pricing. Confirm what a visit involves directly with the practice — 317-455-8540.

GLP-1 access in Indianapolis, Indiana

Adult obesity rate
36.4%
#9 of 50 states (CDC BRFSS)
Avg. compounded semaglutide
$189/mo
Typical Indiana telehealth cash price
Medicaid GLP-1 coverage
Diabetes only
Indiana Medicaid, obesity indication

About 36.4% of Indiana adults have obesity (BMI 30+), ranking the state #9 of 50 (CDC BRFSS). Our directory currently lists 125 GLP-1-relevant clinics in Indianapolis. If a cash-pay route makes more sense, compounded semaglutide through Indiana telehealth averages about $189/mo — well below brand-name Wegovy or Zepbound.

Explore more Indiana options on the best Indiana GLP-1 providers page, browse every Indianapolis listing in the Indianapolis clinic directory, or read the Indiana Medicaid GLP-1 coverage & prior-authorization guide.

Related Practices in Indianapolis

Other Indianapolis listings in the same directory tier:

Telehealth Alternative

Prefer not to visit in person? Licensed GLP-1 telehealth providers ship compounded semaglutide or tirzepatide directly to Indiana addresses, often faster and at lower cash cost than an in-person visit and brand-name prescription. Featured Indiana telehealth partners:

Featured Partners · Indianapolis

Featured GLP-1 providers serving Indianapolis

WeightLossRankings.org is reader-supported. When you buy through links on our site, we may earn an affiliate commission. Learn more

  1. Top pick

    Compounded from

    $249.99/mo

    Save $1,099.01/mo vs Wegovy
    Get started →
  2. Compounded from

    $99/mo

    Save $1,250/mo vs Wegovy
    Get started →
  3. Compounded from

    $199/mo

    Save $1,150/mo vs Wegovy
    Get started →
  4. Compounded from

    $147/mo

    Save $1,202/mo vs Wegovy
    Get started →
  5. 8.2

    Compounded from

    $149/mo

    Save $937/mo vs Zepbound
    Get started →
  6. Compounded from

    $249/mo

    Save $1,100/mo vs Wegovy
    Get started →

See more Indianapolis options on the Indianapolis clinic directory, our Indianapolis GLP-1 telehealth page, or compare the best semaglutide providers nationwide.

Learn more about the medications most commonly prescribed by Indianapolis obesity-medicine and endocrinology practices: Semaglutide and Tirzepatide.

Frequently Asked Questions

The CMS National Provider registry lists Michelle Gilliatte's specialty taxonomy but not the specific medications it prescribes or its current service menu. Michelle Gilliatte is listed under Family Medicine, a field where GLP-1 medications such as semaglutide (Wegovy, Ozempic) or tirzepatide (Zepbound, Mounjaro) are commonly prescribed — but whether this practice currently offers them isn't recorded in the registry. Call the practice at 317-455-8540 to confirm before booking.
According to its CMS National Provider registry (NPPES) record, Michelle Gilliatte's primary specialty on file is Family Medicine, with obesity medicine listed as a secondary taxonomy. Generalist clinicians who carry that secondary designation are among those who commonly manage GLP-1 prescribing, though the registry does not confirm current services.
Michelle Gilliatte is located at 8901 River Crossing Blvd Ste A, Indianapolis, IN 46240. The phone number listed in the registry is 317-455-8540. Its full record is public in the CMS National Provider registry under NPI 1184078909.
New-patient status isn't recorded in the CMS National Provider registry, so we can't confirm whether Michelle Gilliatte is currently accepting new patients. Call the practice at 317-455-8540 to confirm availability, cash-pay pricing, and whether the services you need are offered — this listing reflects the NPPES taxonomy on file and is not an endorsement.